Back to company

Evosep ApS: Financial statements 2021

CVR: 37510068

Evosep ApS (CVR 37510068) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 36,908,323 and a net result of DKK 16,675,475 compared with DKK 6,168,958 the year before. That is an increase of 70.5% compared with the year before. Equity amounted to DKK 45,213,577. The solvency ratio was 79.6%. The company had 20 employees in the financial year.

Gross Profit
36,908,323 kr.
Profit/Loss
16,675,475 kr.
Equity
45,213,577 kr.
Total Assets
56,768,169 kr.
Employees
20

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-36.9 mio.16.7 mio.45.2 mio.20
2020-21.6 mio.6.2 mio.28.5 mio.15
2019-9 mio.-141 t.22.4 mio.-
2018-2.5 mio.-5 mio.22.5 mio.-
2017--2.7 mio.-8.6 mio.7.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Evosep ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Evosep ApS: The 2020 annual report is outMar 11, 2021

Evosep ApS has published its annual report for 2020. Gross profit came to DKK 21,644,268, and the net result was DKK 6,168,958.

About Evosep ApS

Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees. In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity amounted to DKK 154,548,000.